Affimed NV (NASDAQ:AFMD)
| 3.28 Delayed Data As of May 13 |  +0.01 / +0.31%Today’s Change | 2.88 Today|||52-Week Range 9.82 | -40.67% Year-to-Date |
Latest AFMD News | Press Releases
| 3 Small-Caps That Might Be Acquisition Candidates May 09 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.27 |
| Today’s open | 3.24 |
| Day’s range | 3.22 - 3.41 |
| Volume | 864,874 |
| Average volume (3 months) | 1,648,224 |
| Market cap | $477.9M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -0.71% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +47.58% |
| P/E ratio | NM |
| Price/Sales | 13.83 |
| Price/Book | 2.61 |
Competitors
| ---- | ||
| PETQPetIQ Inc | -0.08 | -0.49% |
| ---- | ||
| --Basilea Pharmaceutic... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/13/2022
Financials
| Next reporting date | May 18, 2022 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $47.7M |
| Annual profit (last year) | -$68.0M |
| Net profit margin | -142.50% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
